The state of molecular biomarkers for the early detection of lung cancer.
about
Update in lung cancer and mesothelioma 2012Biomarkers of risk to develop lung cancer in the new screening eraRisk factors assessment and risk prediction models in lung cancer screening candidatesMetabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryLung Cancer Gene Signatures and Clinical PerspectivesUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionProteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS ApproachLiquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancerEarly lung cancer diagnosis by biosensors.Noninvasive Quantitative Imaging-based Biomarkers and Lung Cancer Screening.An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.Circulating endothelial-derived activated microparticle: a useful biomarker for predicting one-year mortality in patients with advanced non-small cell lung cancerNoninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometryBridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraPerformance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry.The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinomaValidation of a multiprotein plasma classifier to identify benign lung nodulesSimilar source of differential blood mRNAs in lung cancer and pulmonary inflammatory diseases: calls for improved strategy for identifying cancer-specific biomarkersBeyond microbial community composition: functional activities of the oral microbiome in health and diseaseBlood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumDifferences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer.Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.Early Detection of Lung Cancer Using Nano-Nose - A Review.Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.Clinical potential of gene mutations in lung cancer.TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levelsCancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.Lung cancer screening update.Facile preparation of salivary extracellular vesicles for cancer proteomics.Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study.Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.Levels of circulating microparticles in lung cancer patients and possible prognostic value.Research status and funding trends of lung cancer biomarkers.Enrichment strategies in glycomics-based lung cancer biomarker development.
P2860
Q24619675-2EE7C60A-867F-44C9-B2E3-294B86732A41Q26747784-54ABA2CC-8E4E-431F-840D-607726BB7557Q26747819-38B1C9C8-1822-4F97-90BC-092CB2189D50Q27144251-4FEB1714-6234-4BB3-83FE-2D7864B83661Q28387769-9EB8EF9A-8331-42DB-B379-BEB021E5067AQ28388931-1A11CAF3-E867-401D-847E-54B9C3F96CE6Q28550766-C4500403-40FD-430B-993D-4C11FA5DD685Q30010613-A3F4AAFA-0798-45E9-886B-0C5CC63BB928Q30449799-2147EDC1-7C04-4D01-BD76-7B8B24AB837BQ33735610-42964AE2-C8D0-4921-867B-30EE7F467F51Q33735718-2535A73F-B43D-4AA8-B4D8-EED5C083DBFBQ33908558-610F8F14-1D62-4D18-A398-CB336329D9AEQ33909660-7B5BF21B-55F4-4EF2-BFA7-F5D82BA7A04FQ34434036-8E1CB007-0ACC-42EE-854B-BD77027DBF0DQ34840130-7CAF17A0-3F69-4EB2-A992-41489CF36B95Q35104929-30F57F7A-B05D-4823-96E8-D4A7D06A7B63Q35119518-DDB8494A-3286-4EC6-99A5-0B043E018398Q35200467-5E94C1DB-FF4C-4FB6-B445-83E41C99B444Q35241794-8E6FB070-FCC1-41E7-92FF-F61B41A0861AQ35268621-64540F43-8562-44D8-965C-99B4EAA70FB8Q35599371-59A50FFB-8AB3-4319-ADD0-FB3BD4D1E7FCQ35957217-6F2C4845-BC2F-443A-9121-B52A80C5A05FQ36100327-093668FE-16A0-4E7D-B7B0-34835A533460Q36248945-F4367194-8D73-49D3-A42C-78123FC54AAFQ36273955-581B7F92-D276-41E6-8FF9-6001DC3B5B9EQ36282745-E6B84B26-0EFA-466C-9305-60354495A8AEQ36297407-91AEBC28-C5BE-4045-A24F-5800809528C2Q36316009-D1033512-304F-4C2F-B253-820EBAF9826DQ36356293-5074D258-A845-41F6-9C65-B8506B32E547Q36557126-C4F4D34D-BF33-4BA7-9428-929DACBD1579Q36639108-466733F1-2322-4749-B5F9-6CF78C2E156BQ36661979-B7185EB5-8873-433F-9077-2FE5A2200938Q36754898-E62A196D-8EF8-45D5-91DD-882AA27D948CQ36810202-7281798E-3C66-49F6-93BA-0A2B124E54B7Q36963678-C2E49396-97E1-4DA9-8369-CFC84BD4980BQ37022332-92969D11-8EA7-4CD9-A708-42B12682875FQ37180356-5C19898C-9536-430B-8F43-5931C3B6736AQ37208677-6CDC407A-4619-4748-9549-B32EEBD2DCB4Q37274578-F5B244AB-7991-489B-9374-87D310E90C97Q37446239-61E06E15-759C-4781-A06F-49282240CE0D
P2860
The state of molecular biomarkers for the early detection of lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The state of molecular biomarkers for the early detection of lung cancer.
@en
The state of molecular biomarkers for the early detection of lung cancer.
@nl
type
label
The state of molecular biomarkers for the early detection of lung cancer.
@en
The state of molecular biomarkers for the early detection of lung cancer.
@nl
prefLabel
The state of molecular biomarkers for the early detection of lung cancer.
@en
The state of molecular biomarkers for the early detection of lung cancer.
@nl
P2093
P2860
P1476
The state of molecular biomarkers for the early detection of lung cancer.
@en
P2093
Carol Callaway-Lane
Eric L Grogan
J Clay Callison
Melinda C Aldrich
Mohamed Hassanein
Pierre P Massion
P2860
P304
P356
10.1158/1940-6207.CAPR-11-0441
P577
2012-06-11T00:00:00Z